0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antibacterial Active Peptide Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-24Z11913
Home | Market Reports | Beauty & Fitness| Face & Body Care
Global Antibacterial Active Peptide Market Research Report 2022
BUY CHAPTERS

Global Antibacterial Active Peptide Market Research Report 2025

Code: QYRE-Auto-24Z11913
Report
February 2025
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Antibacterial Active Peptide Market Size

The global market for Antibacterial Active Peptide was valued at US$ 8490 million in the year 2024 and is projected to reach a revised size of US$ 14990 million by 2031, growing at a CAGR of 8.6% during the forecast period.

Antibacterial Active Peptide Market

Antibacterial Active Peptide Market

Antimicrobial peptides, also known as host defense peptides, are a class of basic polypeptide substances with antibacterial activities related to innate immunity. Antimicrobial peptides have antifungal, antitumor, and antiviral activities, and have the advantages of good thermal stability and specificity. They have good application prospects in the fields of medicine, health care products, agricultural product preservation, feed, and breeding.
Antimicrobial peptides can rapidly kill many microorganisms, including bacteria, fungi, viruses and tumor cells, especially those pathogens that are resistant to multiple antibiotics. Unlike antibiotics that inhibit or kill microorganisms, antimicrobial peptides can kill or inhibit pathogens through a variety of mechanisms, including acting on pathogen cell membranes, maintaining the body"s intestinal health, enhancing the body"s immunity, and regulating host inflammatory responses. Antimicrobial peptides are widely used in the market. In agriculture, they can be used as feed additives and are suitable for raising various animals. In medicine, they can be used as excellent substitutes for antibiotics, and are also considered to be promising drugs that can overcome cancer and AIDS in the future; In industry, it can be used as a green preservative; in human life, it can be used as a substitute for health care products and antibacterial substances. With the continuous improvement of the economy and living standards, people will pay more and more attention to their own health, and the demand for antimicrobial peptides will continue to increase.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antibacterial Active Peptide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibacterial Active Peptide.
The Antibacterial Active Peptide market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antibacterial Active Peptide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibacterial Active Peptide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Antibacterial Active Peptide Market Report

Report Metric Details
Report Name Antibacterial Active Peptide Market
Accounted market size in year US$ 8490 million
Forecasted market size in 2031 US$ 14990 million
CAGR 8.6%
Base Year year
Forecasted years 2025 - 2031
by Type
  • Microbial Antimicrobial Peptides
  • Plant Antimicrobial Peptides
  • Animal Antimicrobial Peptides
  • Others
by Application
  • Food
  • Medical
  • Animal Food
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Lytix Biopharma AS, Genscript, Biosynth Carbosynth, CPC Scientific, Peptilogics, Inc., MaxWell Biosciences, ContraFect Corporation, Lytica Therapeutics , Inc., Amprologix, Ingenza, ReAlta Life Sciences, Celdara Medical, Numaferm, ALLVIVO VASCULAR, INC., Matrubials
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Antibacterial Active Peptide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Antibacterial Active Peptide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Antibacterial Active Peptide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

How fast is Antibacterial Active Peptide Market growing?

Ans: The Antibacterial Active Peptide Market witnessing a CAGR of 8.6% during the forecast period 2025-2031.

What is the Antibacterial Active Peptide Market size in 2031?

Ans: The Antibacterial Active Peptide Market size in 2031 will be US$ 14990 million.

Who are the main players in the Antibacterial Active Peptide Market report?

Ans: The main players in the Antibacterial Active Peptide Market are Lytix Biopharma AS, Genscript, Biosynth Carbosynth, CPC Scientific, Peptilogics, Inc., MaxWell Biosciences, ContraFect Corporation, Lytica Therapeutics , Inc., Amprologix, Ingenza, ReAlta Life Sciences, Celdara Medical, Numaferm, ALLVIVO VASCULAR, INC., Matrubials

What are the Application segmentation covered in the Antibacterial Active Peptide Market report?

Ans: The Applications covered in the Antibacterial Active Peptide Market report are Food, Medical, Animal Food, Others

What are the Type segmentation covered in the Antibacterial Active Peptide Market report?

Ans: The Types covered in the Antibacterial Active Peptide Market report are Microbial Antimicrobial Peptides, Plant Antimicrobial Peptides, Animal Antimicrobial Peptides, Others

1 Antibacterial Active Peptide Market Overview
1.1 Product Definition
1.2 Antibacterial Active Peptide by Type
1.2.1 Global Antibacterial Active Peptide Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Microbial Antimicrobial Peptides
1.2.3 Plant Antimicrobial Peptides
1.2.4 Animal Antimicrobial Peptides
1.2.5 Others
1.3 Antibacterial Active Peptide by Application
1.3.1 Global Antibacterial Active Peptide Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Food
1.3.3 Medical
1.3.4 Animal Food
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Antibacterial Active Peptide Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Antibacterial Active Peptide Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Antibacterial Active Peptide Production Estimates and Forecasts (2020-2031)
1.4.4 Global Antibacterial Active Peptide Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Antibacterial Active Peptide Production Market Share by Manufacturers (2020-2025)
2.2 Global Antibacterial Active Peptide Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Antibacterial Active Peptide, Industry Ranking, 2023 VS 2024
2.4 Global Antibacterial Active Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Antibacterial Active Peptide Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Antibacterial Active Peptide, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Antibacterial Active Peptide, Product Offered and Application
2.8 Global Key Manufacturers of Antibacterial Active Peptide, Date of Enter into This Industry
2.9 Antibacterial Active Peptide Market Competitive Situation and Trends
2.9.1 Antibacterial Active Peptide Market Concentration Rate
2.9.2 Global 5 and 10 Largest Antibacterial Active Peptide Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Antibacterial Active Peptide Production by Region
3.1 Global Antibacterial Active Peptide Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Antibacterial Active Peptide Production Value by Region (2020-2031)
3.2.1 Global Antibacterial Active Peptide Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Antibacterial Active Peptide by Region (2026-2031)
3.3 Global Antibacterial Active Peptide Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Antibacterial Active Peptide Production Volume by Region (2020-2031)
3.4.1 Global Antibacterial Active Peptide Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Antibacterial Active Peptide by Region (2026-2031)
3.5 Global Antibacterial Active Peptide Market Price Analysis by Region (2020-2025)
3.6 Global Antibacterial Active Peptide Production and Value, Year-over-Year Growth
3.6.1 North America Antibacterial Active Peptide Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Antibacterial Active Peptide Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Antibacterial Active Peptide Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Antibacterial Active Peptide Production Value Estimates and Forecasts (2020-2031)
4 Antibacterial Active Peptide Consumption by Region
4.1 Global Antibacterial Active Peptide Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Antibacterial Active Peptide Consumption by Region (2020-2031)
4.2.1 Global Antibacterial Active Peptide Consumption by Region (2020-2025)
4.2.2 Global Antibacterial Active Peptide Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Antibacterial Active Peptide Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Antibacterial Active Peptide Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Antibacterial Active Peptide Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Antibacterial Active Peptide Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Antibacterial Active Peptide Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Antibacterial Active Peptide Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Antibacterial Active Peptide Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Antibacterial Active Peptide Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Antibacterial Active Peptide Production by Type (2020-2031)
5.1.1 Global Antibacterial Active Peptide Production by Type (2020-2025)
5.1.2 Global Antibacterial Active Peptide Production by Type (2026-2031)
5.1.3 Global Antibacterial Active Peptide Production Market Share by Type (2020-2031)
5.2 Global Antibacterial Active Peptide Production Value by Type (2020-2031)
5.2.1 Global Antibacterial Active Peptide Production Value by Type (2020-2025)
5.2.2 Global Antibacterial Active Peptide Production Value by Type (2026-2031)
5.2.3 Global Antibacterial Active Peptide Production Value Market Share by Type (2020-2031)
5.3 Global Antibacterial Active Peptide Price by Type (2020-2031)
6 Segment by Application
6.1 Global Antibacterial Active Peptide Production by Application (2020-2031)
6.1.1 Global Antibacterial Active Peptide Production by Application (2020-2025)
6.1.2 Global Antibacterial Active Peptide Production by Application (2026-2031)
6.1.3 Global Antibacterial Active Peptide Production Market Share by Application (2020-2031)
6.2 Global Antibacterial Active Peptide Production Value by Application (2020-2031)
6.2.1 Global Antibacterial Active Peptide Production Value by Application (2020-2025)
6.2.2 Global Antibacterial Active Peptide Production Value by Application (2026-2031)
6.2.3 Global Antibacterial Active Peptide Production Value Market Share by Application (2020-2031)
6.3 Global Antibacterial Active Peptide Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Lytix Biopharma AS
7.1.1 Lytix Biopharma AS Antibacterial Active Peptide Company Information
7.1.2 Lytix Biopharma AS Antibacterial Active Peptide Product Portfolio
7.1.3 Lytix Biopharma AS Antibacterial Active Peptide Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Lytix Biopharma AS Main Business and Markets Served
7.1.5 Lytix Biopharma AS Recent Developments/Updates
7.2 Genscript
7.2.1 Genscript Antibacterial Active Peptide Company Information
7.2.2 Genscript Antibacterial Active Peptide Product Portfolio
7.2.3 Genscript Antibacterial Active Peptide Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Genscript Main Business and Markets Served
7.2.5 Genscript Recent Developments/Updates
7.3 Biosynth Carbosynth
7.3.1 Biosynth Carbosynth Antibacterial Active Peptide Company Information
7.3.2 Biosynth Carbosynth Antibacterial Active Peptide Product Portfolio
7.3.3 Biosynth Carbosynth Antibacterial Active Peptide Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Biosynth Carbosynth Main Business and Markets Served
7.3.5 Biosynth Carbosynth Recent Developments/Updates
7.4 CPC Scientific
7.4.1 CPC Scientific Antibacterial Active Peptide Company Information
7.4.2 CPC Scientific Antibacterial Active Peptide Product Portfolio
7.4.3 CPC Scientific Antibacterial Active Peptide Production, Value, Price and Gross Margin (2020-2025)
7.4.4 CPC Scientific Main Business and Markets Served
7.4.5 CPC Scientific Recent Developments/Updates
7.5 Peptilogics, Inc.
7.5.1 Peptilogics, Inc. Antibacterial Active Peptide Company Information
7.5.2 Peptilogics, Inc. Antibacterial Active Peptide Product Portfolio
7.5.3 Peptilogics, Inc. Antibacterial Active Peptide Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Peptilogics, Inc. Main Business and Markets Served
7.5.5 Peptilogics, Inc. Recent Developments/Updates
7.6 MaxWell Biosciences
7.6.1 MaxWell Biosciences Antibacterial Active Peptide Company Information
7.6.2 MaxWell Biosciences Antibacterial Active Peptide Product Portfolio
7.6.3 MaxWell Biosciences Antibacterial Active Peptide Production, Value, Price and Gross Margin (2020-2025)
7.6.4 MaxWell Biosciences Main Business and Markets Served
7.6.5 MaxWell Biosciences Recent Developments/Updates
7.7 ContraFect Corporation
7.7.1 ContraFect Corporation Antibacterial Active Peptide Company Information
7.7.2 ContraFect Corporation Antibacterial Active Peptide Product Portfolio
7.7.3 ContraFect Corporation Antibacterial Active Peptide Production, Value, Price and Gross Margin (2020-2025)
7.7.4 ContraFect Corporation Main Business and Markets Served
7.7.5 ContraFect Corporation Recent Developments/Updates
7.8 Lytica Therapeutics , Inc.
7.8.1 Lytica Therapeutics , Inc. Antibacterial Active Peptide Company Information
7.8.2 Lytica Therapeutics , Inc. Antibacterial Active Peptide Product Portfolio
7.8.3 Lytica Therapeutics , Inc. Antibacterial Active Peptide Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Lytica Therapeutics , Inc. Main Business and Markets Served
7.8.5 Lytica Therapeutics , Inc. Recent Developments/Updates
7.9 Amprologix
7.9.1 Amprologix Antibacterial Active Peptide Company Information
7.9.2 Amprologix Antibacterial Active Peptide Product Portfolio
7.9.3 Amprologix Antibacterial Active Peptide Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Amprologix Main Business and Markets Served
7.9.5 Amprologix Recent Developments/Updates
7.10 Ingenza
7.10.1 Ingenza Antibacterial Active Peptide Company Information
7.10.2 Ingenza Antibacterial Active Peptide Product Portfolio
7.10.3 Ingenza Antibacterial Active Peptide Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Ingenza Main Business and Markets Served
7.10.5 Ingenza Recent Developments/Updates
7.11 ReAlta Life Sciences
7.11.1 ReAlta Life Sciences Antibacterial Active Peptide Company Information
7.11.2 ReAlta Life Sciences Antibacterial Active Peptide Product Portfolio
7.11.3 ReAlta Life Sciences Antibacterial Active Peptide Production, Value, Price and Gross Margin (2020-2025)
7.11.4 ReAlta Life Sciences Main Business and Markets Served
7.11.5 ReAlta Life Sciences Recent Developments/Updates
7.12 Celdara Medical
7.12.1 Celdara Medical Antibacterial Active Peptide Company Information
7.12.2 Celdara Medical Antibacterial Active Peptide Product Portfolio
7.12.3 Celdara Medical Antibacterial Active Peptide Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Celdara Medical Main Business and Markets Served
7.12.5 Celdara Medical Recent Developments/Updates
7.13 Numaferm
7.13.1 Numaferm Antibacterial Active Peptide Company Information
7.13.2 Numaferm Antibacterial Active Peptide Product Portfolio
7.13.3 Numaferm Antibacterial Active Peptide Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Numaferm Main Business and Markets Served
7.13.5 Numaferm Recent Developments/Updates
7.14 ALLVIVO VASCULAR, INC.
7.14.1 ALLVIVO VASCULAR, INC. Antibacterial Active Peptide Company Information
7.14.2 ALLVIVO VASCULAR, INC. Antibacterial Active Peptide Product Portfolio
7.14.3 ALLVIVO VASCULAR, INC. Antibacterial Active Peptide Production, Value, Price and Gross Margin (2020-2025)
7.14.4 ALLVIVO VASCULAR, INC. Main Business and Markets Served
7.14.5 ALLVIVO VASCULAR, INC. Recent Developments/Updates
7.15 Matrubials
7.15.1 Matrubials Antibacterial Active Peptide Company Information
7.15.2 Matrubials Antibacterial Active Peptide Product Portfolio
7.15.3 Matrubials Antibacterial Active Peptide Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Matrubials Main Business and Markets Served
7.15.5 Matrubials Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Antibacterial Active Peptide Industry Chain Analysis
8.2 Antibacterial Active Peptide Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Antibacterial Active Peptide Production Mode & Process Analysis
8.4 Antibacterial Active Peptide Sales and Marketing
8.4.1 Antibacterial Active Peptide Sales Channels
8.4.2 Antibacterial Active Peptide Distributors
8.5 Antibacterial Active Peptide Customer Analysis
9 Antibacterial Active Peptide Market Dynamics
9.1 Antibacterial Active Peptide Industry Trends
9.2 Antibacterial Active Peptide Market Drivers
9.3 Antibacterial Active Peptide Market Challenges
9.4 Antibacterial Active Peptide Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global Antibacterial Active Peptide Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Antibacterial Active Peptide Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Antibacterial Active Peptide Production Capacity (Tons) by Manufacturers in 2024
 Table 4. Global Antibacterial Active Peptide Production by Manufacturers (2020-2025) & (Tons)
 Table 5. Global Antibacterial Active Peptide Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Antibacterial Active Peptide Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Antibacterial Active Peptide Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Antibacterial Active Peptide, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Antibacterial Active Peptide as of 2024)
 Table 10. Global Market Antibacterial Active Peptide Average Price by Manufacturers (US$/Ton) & (2020-2025)
 Table 11. Global Key Manufacturers of Antibacterial Active Peptide, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Antibacterial Active Peptide, Product Offered and Application
 Table 13. Global Key Manufacturers of Antibacterial Active Peptide, Date of Enter into This Industry
 Table 14. Global Antibacterial Active Peptide Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Antibacterial Active Peptide Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Antibacterial Active Peptide Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Antibacterial Active Peptide Production Value Market Share by Region (2020-2025)
 Table 19. Global Antibacterial Active Peptide Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Antibacterial Active Peptide Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Antibacterial Active Peptide Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 22. Global Antibacterial Active Peptide Production (Tons) by Region (2020-2025)
 Table 23. Global Antibacterial Active Peptide Production Market Share by Region (2020-2025)
 Table 24. Global Antibacterial Active Peptide Production (Tons) Forecast by Region (2026-2031)
 Table 25. Global Antibacterial Active Peptide Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Antibacterial Active Peptide Market Average Price (US$/Ton) by Region (2020-2025)
 Table 27. Global Antibacterial Active Peptide Market Average Price (US$/Ton) by Region (2026-2031)
 Table 28. Global Antibacterial Active Peptide Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 29. Global Antibacterial Active Peptide Consumption by Region (2020-2025) & (Tons)
 Table 30. Global Antibacterial Active Peptide Consumption Market Share by Region (2020-2025)
 Table 31. Global Antibacterial Active Peptide Forecasted Consumption by Region (2026-2031) & (Tons)
 Table 32. Global Antibacterial Active Peptide Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Antibacterial Active Peptide Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 34. North America Antibacterial Active Peptide Consumption by Country (2020-2025) & (Tons)
 Table 35. North America Antibacterial Active Peptide Consumption by Country (2026-2031) & (Tons)
 Table 36. Europe Antibacterial Active Peptide Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 37. Europe Antibacterial Active Peptide Consumption by Country (2020-2025) & (Tons)
 Table 38. Europe Antibacterial Active Peptide Consumption by Country (2026-2031) & (Tons)
 Table 39. Asia Pacific Antibacterial Active Peptide Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 40. Asia Pacific Antibacterial Active Peptide Consumption by Region (2020-2025) & (Tons)
 Table 41. Asia Pacific Antibacterial Active Peptide Consumption by Region (2026-2031) & (Tons)
 Table 42. Latin America, Middle East & Africa Antibacterial Active Peptide Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 43. Latin America, Middle East & Africa Antibacterial Active Peptide Consumption by Country (2020-2025) & (Tons)
 Table 44. Latin America, Middle East & Africa Antibacterial Active Peptide Consumption by Country (2026-2031) & (Tons)
 Table 45. Global Antibacterial Active Peptide Production (Tons) by Type (2020-2025)
 Table 46. Global Antibacterial Active Peptide Production (Tons) by Type (2026-2031)
 Table 47. Global Antibacterial Active Peptide Production Market Share by Type (2020-2025)
 Table 48. Global Antibacterial Active Peptide Production Market Share by Type (2026-2031)
 Table 49. Global Antibacterial Active Peptide Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Antibacterial Active Peptide Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Antibacterial Active Peptide Production Value Market Share by Type (2020-2025)
 Table 52. Global Antibacterial Active Peptide Production Value Market Share by Type (2026-2031)
 Table 53. Global Antibacterial Active Peptide Price (US$/Ton) by Type (2020-2025)
 Table 54. Global Antibacterial Active Peptide Price (US$/Ton) by Type (2026-2031)
 Table 55. Global Antibacterial Active Peptide Production (Tons) by Application (2020-2025)
 Table 56. Global Antibacterial Active Peptide Production (Tons) by Application (2026-2031)
 Table 57. Global Antibacterial Active Peptide Production Market Share by Application (2020-2025)
 Table 58. Global Antibacterial Active Peptide Production Market Share by Application (2026-2031)
 Table 59. Global Antibacterial Active Peptide Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Antibacterial Active Peptide Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Antibacterial Active Peptide Production Value Market Share by Application (2020-2025)
 Table 62. Global Antibacterial Active Peptide Production Value Market Share by Application (2026-2031)
 Table 63. Global Antibacterial Active Peptide Price (US$/Ton) by Application (2020-2025)
 Table 64. Global Antibacterial Active Peptide Price (US$/Ton) by Application (2026-2031)
 Table 65. Lytix Biopharma AS Antibacterial Active Peptide Company Information
 Table 66. Lytix Biopharma AS Antibacterial Active Peptide Specification and Application
 Table 67. Lytix Biopharma AS Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 68. Lytix Biopharma AS Main Business and Markets Served
 Table 69. Lytix Biopharma AS Recent Developments/Updates
 Table 70. Genscript Antibacterial Active Peptide Company Information
 Table 71. Genscript Antibacterial Active Peptide Specification and Application
 Table 72. Genscript Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 73. Genscript Main Business and Markets Served
 Table 74. Genscript Recent Developments/Updates
 Table 75. Biosynth Carbosynth Antibacterial Active Peptide Company Information
 Table 76. Biosynth Carbosynth Antibacterial Active Peptide Specification and Application
 Table 77. Biosynth Carbosynth Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 78. Biosynth Carbosynth Main Business and Markets Served
 Table 79. Biosynth Carbosynth Recent Developments/Updates
 Table 80. CPC Scientific Antibacterial Active Peptide Company Information
 Table 81. CPC Scientific Antibacterial Active Peptide Specification and Application
 Table 82. CPC Scientific Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 83. CPC Scientific Main Business and Markets Served
 Table 84. CPC Scientific Recent Developments/Updates
 Table 85. Peptilogics, Inc. Antibacterial Active Peptide Company Information
 Table 86. Peptilogics, Inc. Antibacterial Active Peptide Specification and Application
 Table 87. Peptilogics, Inc. Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 88. Peptilogics, Inc. Main Business and Markets Served
 Table 89. Peptilogics, Inc. Recent Developments/Updates
 Table 90. MaxWell Biosciences Antibacterial Active Peptide Company Information
 Table 91. MaxWell Biosciences Antibacterial Active Peptide Specification and Application
 Table 92. MaxWell Biosciences Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. MaxWell Biosciences Main Business and Markets Served
 Table 94. MaxWell Biosciences Recent Developments/Updates
 Table 95. ContraFect Corporation Antibacterial Active Peptide Company Information
 Table 96. ContraFect Corporation Antibacterial Active Peptide Specification and Application
 Table 97. ContraFect Corporation Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 98. ContraFect Corporation Main Business and Markets Served
 Table 99. ContraFect Corporation Recent Developments/Updates
 Table 100. Lytica Therapeutics , Inc. Antibacterial Active Peptide Company Information
 Table 101. Lytica Therapeutics , Inc. Antibacterial Active Peptide Specification and Application
 Table 102. Lytica Therapeutics , Inc. Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 103. Lytica Therapeutics , Inc. Main Business and Markets Served
 Table 104. Lytica Therapeutics , Inc. Recent Developments/Updates
 Table 105. Amprologix Antibacterial Active Peptide Company Information
 Table 106. Amprologix Antibacterial Active Peptide Specification and Application
 Table 107. Amprologix Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 108. Amprologix Main Business and Markets Served
 Table 109. Amprologix Recent Developments/Updates
 Table 110. Ingenza Antibacterial Active Peptide Company Information
 Table 111. Ingenza Antibacterial Active Peptide Specification and Application
 Table 112. Ingenza Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 113. Ingenza Main Business and Markets Served
 Table 114. Ingenza Recent Developments/Updates
 Table 115. ReAlta Life Sciences Antibacterial Active Peptide Company Information
 Table 116. ReAlta Life Sciences Antibacterial Active Peptide Specification and Application
 Table 117. ReAlta Life Sciences Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 118. ReAlta Life Sciences Main Business and Markets Served
 Table 119. ReAlta Life Sciences Recent Developments/Updates
 Table 120. Celdara Medical Antibacterial Active Peptide Company Information
 Table 121. Celdara Medical Antibacterial Active Peptide Specification and Application
 Table 122. Celdara Medical Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 123. Celdara Medical Main Business and Markets Served
 Table 124. Celdara Medical Recent Developments/Updates
 Table 125. Numaferm Antibacterial Active Peptide Company Information
 Table 126. Numaferm Antibacterial Active Peptide Specification and Application
 Table 127. Numaferm Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 128. Numaferm Main Business and Markets Served
 Table 129. Numaferm Recent Developments/Updates
 Table 130. ALLVIVO VASCULAR, INC. Antibacterial Active Peptide Company Information
 Table 131. ALLVIVO VASCULAR, INC. Antibacterial Active Peptide Specification and Application
 Table 132. ALLVIVO VASCULAR, INC. Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 133. ALLVIVO VASCULAR, INC. Main Business and Markets Served
 Table 134. ALLVIVO VASCULAR, INC. Recent Developments/Updates
 Table 135. Matrubials Antibacterial Active Peptide Company Information
 Table 136. Matrubials Antibacterial Active Peptide Specification and Application
 Table 137. Matrubials Antibacterial Active Peptide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 138. Matrubials Main Business and Markets Served
 Table 139. Matrubials Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Antibacterial Active Peptide Distributors List
 Table 143. Antibacterial Active Peptide Customers List
 Table 144. Antibacterial Active Peptide Market Trends
 Table 145. Antibacterial Active Peptide Market Drivers
 Table 146. Antibacterial Active Peptide Market Challenges
 Table 147. Antibacterial Active Peptide Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Antibacterial Active Peptide
 Figure 2. Global Antibacterial Active Peptide Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Antibacterial Active Peptide Market Share by Type: 2024 VS 2031
 Figure 4. Microbial Antimicrobial Peptides Product Picture
 Figure 5. Plant Antimicrobial Peptides Product Picture
 Figure 6. Animal Antimicrobial Peptides Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Antibacterial Active Peptide Market Value by Application, (US$ Million) & (2020-2031)
 Figure 9. Global Antibacterial Active Peptide Market Share by Application: 2024 VS 2031
 Figure 10. Food
 Figure 11. Medical
 Figure 12. Animal Food
 Figure 13. Others
 Figure 14. Global Antibacterial Active Peptide Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Antibacterial Active Peptide Production Value (US$ Million) & (2020-2031)
 Figure 16. Global Antibacterial Active Peptide Production Capacity (Tons) & (2020-2031)
 Figure 17. Global Antibacterial Active Peptide Production (Tons) & (2020-2031)
 Figure 18. Global Antibacterial Active Peptide Average Price (US$/Ton) & (2020-2031)
 Figure 19. Antibacterial Active Peptide Report Years Considered
 Figure 20. Antibacterial Active Peptide Production Share by Manufacturers in 2024
 Figure 21. Global Antibacterial Active Peptide Production Value Share by Manufacturers (2024)
 Figure 22. Antibacterial Active Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. The Global 5 and 10 Largest Players: Market Share by Antibacterial Active Peptide Revenue in 2024
 Figure 24. Global Antibacterial Active Peptide Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 25. Global Antibacterial Active Peptide Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 26. Global Antibacterial Active Peptide Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 27. Global Antibacterial Active Peptide Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 28. North America Antibacterial Active Peptide Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 29. Europe Antibacterial Active Peptide Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 30. China Antibacterial Active Peptide Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 31. Japan Antibacterial Active Peptide Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 32. Global Antibacterial Active Peptide Consumption by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 33. Global Antibacterial Active Peptide Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 34. North America Antibacterial Active Peptide Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 35. North America Antibacterial Active Peptide Consumption Market Share by Country (2020-2031)
 Figure 36. U.S. Antibacterial Active Peptide Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 37. Canada Antibacterial Active Peptide Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 38. Europe Antibacterial Active Peptide Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 39. Europe Antibacterial Active Peptide Consumption Market Share by Country (2020-2031)
 Figure 40. Germany Antibacterial Active Peptide Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 41. France Antibacterial Active Peptide Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 42. U.K. Antibacterial Active Peptide Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 43. Italy Antibacterial Active Peptide Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 44. Russia Antibacterial Active Peptide Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 45. Asia Pacific Antibacterial Active Peptide Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 46. Asia Pacific Antibacterial Active Peptide Consumption Market Share by Region (2020-2031)
 Figure 47. China Antibacterial Active Peptide Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 48. Japan Antibacterial Active Peptide Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 49. South Korea Antibacterial Active Peptide Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 50. China Taiwan Antibacterial Active Peptide Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 51. Southeast Asia Antibacterial Active Peptide Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 52. India Antibacterial Active Peptide Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 53. Latin America, Middle East & Africa Antibacterial Active Peptide Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 54. Latin America, Middle East & Africa Antibacterial Active Peptide Consumption Market Share by Country (2020-2031)
 Figure 55. Mexico Antibacterial Active Peptide Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 56. Brazil Antibacterial Active Peptide Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 57. Turkey Antibacterial Active Peptide Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 58. GCC Countries Antibacterial Active Peptide Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 59. Global Production Market Share of Antibacterial Active Peptide by Type (2020-2031)
 Figure 60. Global Production Value Market Share of Antibacterial Active Peptide by Type (2020-2031)
 Figure 61. Global Antibacterial Active Peptide Price (US$/Ton) by Type (2020-2031)
 Figure 62. Global Production Market Share of Antibacterial Active Peptide by Application (2020-2031)
 Figure 63. Global Production Value Market Share of Antibacterial Active Peptide by Application (2020-2031)
 Figure 64. Global Antibacterial Active Peptide Price (US$/Ton) by Application (2020-2031)
 Figure 65. Antibacterial Active Peptide Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Deodorant Finishing Agent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8D14224
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Skin Feel Enhancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11I13072
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Antiperspirant Aluminum Chlorohydrate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10X12967
Fri Mar 21 00:00:00 UTC 2025

Add to Cart

Global Cosmetics-grade Marula Oil Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9P15880
Fri Mar 21 00:00:00 UTC 2025

Add to Cart